Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desvenlafaxine for Hot Flashes in Breast Cancer Patients on Tamoxifen
NCT02819921Phase 4Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of desvenlafaxine in hot flashes (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Reduction rate of hot flashes symptom score at Week 5. Started Nov 2017; status: terminated.
02
Drugs
desvenlafaxine
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT02819921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819921.